Savara (FRA:YB4P) Beginning Cash Position : €21.50 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Savara Beginning Cash Position?

Savara's Beginning Cash Position for the quarter that ended in Sep. 2024 was €21.50 Mil.

Savara's quarterly Beginning Cash Position declined from Mar. 2024 (€24.46 Mil) to Jun. 2024 (€15.59 Mil) but then increased from Jun. 2024 (€15.59 Mil) to Sep. 2024 (€21.50 Mil).

Savara's annual Beginning Cash Position increased from Dec. 2021 (€20.25 Mil) to Dec. 2022 (€32.11 Mil) and increased from Dec. 2022 (€32.11 Mil) to Dec. 2023 (€47.78 Mil).

Savara Beginning Cash Position Historical Data

The historical data trend for Savara's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara Beginning Cash Position Chart

Savara Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

21.87

40.94

20.25

32.11

47.78

Savara Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															21.31	25.39	24.46	15.59	21.50

Savara Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Savara Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Savara's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Savara Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SVRA:USA

Address

1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 78746

Website

https://www.savarapharma.com

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Headlines

No Headlines